WHO Reports Malaria Vaccine Significantly Reduces Child Deaths in Africa
New evidence highlights the life-saving impact of malaria vaccination programs across Africa.
Source: UN NewsThe World Health Organization (WHO) has announced that new evidence confirms malaria vaccination is significantly reducing child deaths in Africa. This positive development suggests that expanding vaccination programs could lead to an even greater impact on public health. The WHO's findings underscore the critical role of these vaccines in combating malaria, a disease that disproportionately affects children in sub-Saharan Africa. This progress offers hope for achieving global health targets and saving countless young lives from this preventable disease.
- The World Health Organization (WHO) confirmed that malaria vaccination is significantly reducing child deaths in Africa.
- New evidence suggests that expanding these vaccination programs could lead to an even greater positive impact.
- The RTS,S/AS01 (Mosquirix) vaccine was the first malaria vaccine recommended by WHO in 2021 for widespread use.
- It is primarily recommended for children living in regions with moderate to high Plasmodium falciparum malaria transmission.
- A second malaria vaccine, R21/Matrix-M, was also recommended by WHO in 2023.
Founded in 1948, headquartered in Geneva, Switzerland. It is a specialized agency of the United Nations responsible for international public health. Its main goal is to promote health, keep the world safe, and serve the vulnerable.
A serious and sometimes fatal disease caused by a parasite that commonly infects a certain type of mosquito which feeds on humans. It is preventable and curable, primarily affecting tropical and subtropical regions.
The world's first malaria vaccine recommended by WHO, targeting the Plasmodium falciparum parasite, which is most prevalent in Africa. It provides partial protection against malaria in young children.
The science and art of preventing disease, prolonging life, and promoting health through the organized efforts and informed choices of society, organizations, public and private communities, and individuals.
Questions often focus on the first approved malaria vaccine (RTS,S/AS01), its target population, the disease vector, and the role of WHO in global health initiatives.
Remember WHO's report on Malaria Vaccine: 'WHO Saves Kids from Malaria' (WSKM) highlights the organization, the disease, the intervention, and the outcome.